Characterization and identification of the inhibitory domain of GDF-8 propeptide

被引:94
作者
Jiang, MS [1 ]
Liang, LF
Wang, SS
Ratovitski, T
Holmstrom, J
Barker, C
Stotish, R
机构
[1] MetaMorphix Inc, Savage, MD 20763 USA
[2] MetaMorphix Canada Inc, Saskatoon, SK S7N 3R2, Canada
关键词
D O I
10.1016/j.bbrc.2004.01.085
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
GDF-8 is a negative regulator of skeletal muscle mass. The mechanisms which regulate the biological activity of GDF-8 have not yet been elucidated. Analogous to the TGF-beta system, GDF-8 propeptide binds to and inhibits the activity of GDF-8. In these studies, we define the critical domain of the GDF-8 propeptide necessary for inhibitory activity. Two molecules of GDF-8 propeptide monomer inhibit the biological activity of one molecule of GDF-8 homodimer. Although the propeptide contains N-linked glycosylation when synthesized in mammalian cells, this glycosylation is not necessary for the inhibition of GDF-8. Taking advantage of the bacterial expression system, we express and purify GDF-8 propeptide which retains full inhibitory activity. To define the functional regions of the propeptide, we express a series of truncated GST-propeptide fusion proteins and examined their inhibitory activity. We observe that fusion proteins containing the C-terminal region (amino acid residues 99-266) are very stable, but do not exhibit inhibitory activity; while fusion proteins containing the N-terminal region (amino acid residues 42-115) are labile but contain essential inhibitory activity. The data suggest that the C-terminal region may play a role in the stability of the GDF-8 propeptide and that the inhibitory domain is located in the region between amino acids 42 and 115. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:525 / 531
页数:7
相关论文
共 32 条
[1]   The regulation and action of myostatin as a negative regulator of muscle development during avian embryogenesis [J].
Amthor, H ;
Huang, RJ ;
McKinnell, I ;
Christ, B ;
Kambadur, R ;
Sharma, M ;
Patel, K .
DEVELOPMENTAL BIOLOGY, 2002, 251 (02) :241-257
[2]  
ASHMORE CR, 1974, GROWTH, V38, P501
[3]   Functional improvement of dystrophic muscle by myostatin blockade [J].
Bogdanovich, S ;
Krag, TOB ;
Barton, ER ;
Morris, LD ;
Whittemore, LA ;
Ahima, RS ;
Khurana, TS .
NATURE, 2002, 420 (6914) :418-421
[4]   X-CHROMOSOME-LINKED MUSCULAR-DYSTROPHY (MDX) IN THE MOUSE [J].
BULFIELD, G ;
SILLER, WG ;
WIGHT, PAL ;
MOORE, KJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (04) :1189-1192
[5]   THE MDX MOUSE SKELETAL-MUSCLE MYOPATHY .1. A HISTOLOGICAL, MORPHOMETRIC AND BIOCHEMICAL INVESTIGATION [J].
COULTON, GR ;
MORGAN, JE ;
PARTRIDGE, TA ;
SLOPER, JC .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1988, 14 (01) :53-70
[6]   Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene [J].
Dennler, S ;
Itoh, S ;
Vivien, D ;
ten Dijke, P ;
Huet, S ;
Gauthier, JM .
EMBO JOURNAL, 1998, 17 (11) :3091-3100
[7]   Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene [J].
Grobet, L ;
Pirottin, D ;
Farnir, F ;
Poncelet, D ;
Royo, LJ ;
Brouwers, B ;
Christians, E ;
Desmecht, D ;
Coignoul, F ;
Kahn, R ;
Georges, M .
GENESIS, 2003, 35 (04) :227-238
[8]   A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle [J].
Grobet, L ;
Martin, LJR ;
Poncelet, D ;
Pirottin, D ;
Brouwers, B ;
Riquet, J ;
Schoeberlein, A ;
Dunner, S ;
Menissier, F ;
Massabanda, J ;
Fries, R ;
Hanset, R ;
Georges, M .
NATURE GENETICS, 1997, 17 (01) :71-74
[9]   Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle [J].
Grobet, L ;
Poncelet, D ;
Royo, LJ ;
Brouwers, B ;
Pirottin, D ;
Michaux, C ;
Ménissier, F ;
Zanotti, M ;
Dunner, S ;
Georges, M .
MAMMALIAN GENOME, 1998, 9 (03) :210-213
[10]   The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum [J].
Hill, JJ ;
Davies, MV ;
Pearson, AA ;
Wang, JH ;
Hewick, RM ;
Wolfman, NM ;
Qiu, YC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) :40735-40741